DJIA 16,107.62 -420.41 -2.54%
NASDAQ 4,659.72 -116.79 -2.45%
S&P 500 1,918.83 -53.35 -2.71%
market minute promo

172.62 0.43 (0.25%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ALXN $172.62 0.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $168.62
Previous Close $172.19
Daily Range $168.08 - $174.78
52-Week Range $150.06 - $208.88
Market Cap $39.0B
P/E Ratio 58.77
Dividend (Yield) $0.00 (0.0%)
Volume 1,426,123
Average Daily Volume 1,533,061
Current FY EPS $4.58




Drug Makers

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website:

News & Commentary

This Drugmaker's Incredible Run Looks Far From Done

Alexion Pharmaceuticals has been a biotech investor's dream stock for years and has created a fortune for patient investors. But with a strong product lineup and healthy pipeline, the future looks great, too.

Biotech Review (Part 2 Of 3): New Coverage Of Some Mid-Caps With Update On Intercept

UBS Picks 22 Stocks for Their 'Cash Cushions' for Times of Market Volatility

Short Sellers Become More Focused in Major Biotechs

Oversold Conditions For Alexion Pharmaceuticals (ALXN)

Alexion Pharmaceuticals Will Rise Again

Falling Earnings Estimates Signal Weakness Ahead for Alexion Pharmaceuticals (ALXN)

Wall Street Breakfast: Crude Prices Head To The $30s

Omeros' Reveals Positive Data on OMS721 from Phase II

David Swensen Buys Stake in Vanguard MSCI Emerging Markets ETF

Baron Funds Comments on Alexion Pharmaceuticals Inc.

See More ALXN News...

ALXN's Top Competitors

ALXN $172.62 (0.25%)
Current stock: ALXN
AMGN $148.55 (-2.13%)
Current stock: AMGN
GILD $102.22 (-2.71%)
Current stock: GILD
BIIB $295.77 (-0.51%)
Current stock: BIIB